Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2018 4
2020 2
2021 1
2022 1
2023 1
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Management of patients with metastatic breast cancer.
Cruz Jurado J, Richart Aznar P, García Mata J, Fernández Martínez R, Peláez Fernández I, Sampedro Gimeno T, Galve Calvo E, Murillo Jaso L, Polo Marqués E, García Palomo A. Cruz Jurado J, et al. Among authors: galve calvo e. Adv Ther. 2011 Sep;28 Suppl 6:50-65. doi: 10.1007/s12325-011-0046-9. Epub 2011 Sep 16. Adv Ther. 2011. PMID: 21922395 Review.
Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer.
Ayala de la Peña F, Ortiz-Muñoz B, Quintanar-Verdúguez T, Santotoribio JD, de la Cruz S, Trapé-Pujol J, Galve-Calvo E, Augé-Fradera JM, García-Gómez J, González-Hernández Á. Ayala de la Peña F, et al. Among authors: galve calvo e. Clin Transl Oncol. 2021 Jul;23(7):1272-1280. doi: 10.1007/s12094-020-02529-x. Epub 2021 Feb 7. Clin Transl Oncol. 2021. PMID: 33550504 Free PMC article.
The economic burden of metastatic breast cancer in Spain.
Bermejo de Las Heras B, Cortes Ramon Y Cajal J, Galve Calvo E, de la Haba Rodriguez J, Garcia Mata J, Moreno Anton F, Pelaez Fernandez I, Rodriguez-Lescure A, Rodriguez Sanchez CA, Ruiz-Borrego M, Remak E, Barra M, Rivero M, Soto Alvarez J. Bermejo de Las Heras B, et al. Among authors: galve calvo e. Eur J Hosp Pharm. 2020 Jan;27(1):19-24. doi: 10.1136/ejhpharm-2017-001453. Epub 2018 Jul 30. Eur J Hosp Pharm. 2020. PMID: 32064084 Free PMC article.
First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN.
Martínez-Jañez N, Ezquerra MB, Manso Sanchez LM, Carrasco FH, Torres AA, Morales S, Ortega PT, Gil VLO, Sampedro T, Conejero RA, Calvo-Martinez L, Galve-Calvo E, López R, de la Pena FA, Lopez-Tarruella S, de Araguiz BAHF, Ruiz LB, Cardenas TM, Chacon JI, Antón FM. Martínez-Jañez N, et al. Among authors: galve calvo e. Breast Cancer Res Treat. 2024 Jul;206(2):317-328. doi: 10.1007/s10549-024-07287-w. Epub 2024 Apr 1. Breast Cancer Res Treat. 2024. PMID: 38561577 Free PMC article.
Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients.
Falcón González A, Gallegos Sancho MI, González Flores E, Galve Calvo E, Ruiz Vozmediano J, Domingo García P, López Martos R, Sánchez Rivas E, Iglesias Urraca CM, Gómez Calvo AI, De Mariscal Polo A, Ramos-Medina R, Rivero M, Martínez Marín V. Falcón González A, et al. Among authors: galve calvo e. Clin Transl Oncol. 2024 Aug 29. doi: 10.1007/s12094-024-03636-9. Online ahead of print. Clin Transl Oncol. 2024. PMID: 39210207
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial.
Salvador Bofill J, Moreno Anton F, Rodriguez Sanchez CA, Galve Calvo E, Hernando Melia C, Ciruelos Gil EM, Vidal M, Jiménez-Rodriguez B, De la Cruz Merino L, Martínez Jañez N, Villanueva Vazquez R, de Toro Salas R, Anton Torres A, Alvarez Lopez IM, Gavila Gregori J, Quiroga Garcia V, Vicente Rubio E, De la Haba-Rodriguez J, Gonzalez-Santiago S, Diaz Fernandez N, Barnadas Molins A, Cantos Sanchez de Ibargüen B, Delgado Mingorance JI, Bellet Ezquerra M, de Casa S, Gimeno A, Martin M. Salvador Bofill J, et al. Among authors: galve calvo e. Breast. 2022 Dec;66:77-84. doi: 10.1016/j.breast.2022.09.006. Epub 2022 Sep 28. Breast. 2022. PMID: 36206609 Free PMC article. Clinical Trial.
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals.
Martínez Del Prado P, Alvarez-López I, Domínguez-Fernández S, Plazaola A, Ibarrondo O, Galve-Calvo E, Ancizar-Lizarraga N, Gutierrez-Toribio M, Lahuerta-Martínez A, Mar J. Martínez Del Prado P, et al. Among authors: galve calvo e. Clinicoecon Outcomes Res. 2018 Mar 19;10:189-199. doi: 10.2147/CEOR.S146095. eCollection 2018. Clinicoecon Outcomes Res. 2018. PMID: 29593426 Free PMC article.
11 results